Trial · NCT03155997
Adverse events848
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
201 to 220 of 848
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dysuria | Renal and urinary disorders | 150 mg Abemaciclib + Endocrine Therapy | 46 | 2,791 | 53 |
| other | Dysuria | Renal and urinary disorders | Endocrine Therapy | 25 | 2,800 | 29 |
| other | Breast pain | Reproductive system and breast disorders | 150 mg Abemaciclib + Endocrine Therapy | 95 | 2,791 | 104 |
| other | Breast pain | Reproductive system and breast disorders | Endocrine Therapy | 120 | 2,800 | 133 |
| other | Erectile dysfunction | Reproductive system and breast disorders | 150 mg Abemaciclib + Endocrine Therapy | 1 | 21 | 1 |
| other | Erectile dysfunction | Reproductive system and breast disorders | Endocrine Therapy | 0 | 15 | 0 |
| other | Vaginal discharge | Reproductive system and breast disorders | 150 mg Abemaciclib + Endocrine Therapy | 26 | 2,770 | 27 |
| other | Vaginal discharge | Reproductive system and breast disorders | Endocrine Therapy | 39 | 2,785 | 42 |
| other | Vulvovaginal dryness | Reproductive system and breast disorders | 150 mg Abemaciclib + Endocrine Therapy | 78 | 2,770 | 80 |
| other | Vulvovaginal dryness | Reproductive system and breast disorders | Endocrine Therapy | 117 | 2,785 | 127 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 337 | 2,791 | 407 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Endocrine Therapy | 193 | 2,800 | 228 |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 139 | 2,791 | 154 |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Endocrine Therapy | 77 | 2,800 | 86 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 49 | 2,791 | 52 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Endocrine Therapy | 8 | 2,800 | 10 |
| other | Nasal congestion | Respiratory, thoracic and mediastinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 34 | 2,791 | 37 |
| other | Nasal congestion | Respiratory, thoracic and mediastinal disorders | Endocrine Therapy | 29 | 2,800 | 33 |
| other | Oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | 150 mg Abemaciclib + Endocrine Therapy | 115 | 2,791 | 142 |
| other | Oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | Endocrine Therapy | 76 | 2,800 | 91 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03155997/events?page=11